MBM's Regulatory Practice Group

MBM services single regulatorypractice

MBM's Regulatory Practice Group advises clients on a broad range of regulatory issues related to drugs, natural health products, medical devices/diagnostics, food and cosmetics.  It is comprised of a multidisciplinary group of practitioners with past experience working at Health Canada in the application and enforcement of the Food & Drug Act and associated regulations, as well as working within major pharmaceutical companies:

Our expertise includes, but is not limited to, the following:

  • Classification of products under the various regulatory regimes;
  • Manoeuvring through the regulatory approval process including pre-submission and submission activities with regulatory authorities and appeals of submission decisions;
  • Patent listing under the Patented Medicines (Notice of Compliance) Regulations and eligibility for data protection/exclusivity; and
  • Application of the Patented Medicine Prices Review Board and formulary listing and reimbursement. 

 

 

Submit to DiggSubmit to FacebookSubmit to Google BookmarksSubmit to StumbleuponSubmit to TwitterSubmit to LinkedIn

cb photo 70 563d0138742d9

DR. Stuart Bristowe

Patent Agent


Stuart’s practice focuses on the drafting and prosecution of patent applications in various areas of technology.MBM read_more_btn

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

LION NOW ROARS LOUDER IN CANADA

It has been a long-standing position of the Canadian Intellectual Property Office that sounds cannot function as trademarks.  While many countries in the world recognize and routinely register sound marks....Read More